Kodiak Sciences KOD
NASDAQ KOD
$98.46 +3.66 (+3.86%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kodiak Sciences (KOD) Liabilities and Shareholders Equity (2017 - 2026)

Updated

Kodiak Sciences' Liabilities and Shareholders Equity was $256.81 million in Q2 2026, unchanged from $256.73 million a year earlier and down 16.1% from the prior quarter.

Analysis

Kodiak Sciences (KOD) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Kodiak Sciences came in at $351.53 million, up 4.8% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -19.9% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $335.58 million in FY2024 (-30.0%), $479.37 million in FY2023 (-28.1%), $666.63 million in FY2022 (-26.3%) and $904.22 million in FY2021 (-15.3%).
  • Quarterly Liabilities and Shareholders Equity has moved between $218.07 million (Q3 2025) and $958.21 million (Q3 2021) over five years.
  • Compared with a year earlier, Liabilities and Shareholders Equity was higher in two of the last eight quarters, with an average decline of 20.4%.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q3 2021 (growth of 99.3%); the worst was Q3 2025 (a decline of 41.5%).
  • Per Business Quant data, KOD's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $306.01 million (Q1 2026), $351.53 million (Q4 2025) and $218.07 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Kodiak Sciences 5.96 Bn 5.96 Bn - 256.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 256.81 Mn
Mar 31, 2026 306.01 Mn
Dec 31, 2025 351.53 Mn
Sep 30, 2025 218.07 Mn
Jun 30, 2025 256.73 Mn
Mar 31, 2025 297.91 Mn
Dec 31, 2024 335.58 Mn
Sep 30, 2024 372.67 Mn
Jun 30, 2024 401.58 Mn
Mar 31, 2024 434.76 Mn
Dec 31, 2023 479.37 Mn
Sep 30, 2023 547.65 Mn
Jun 30, 2023 589.66 Mn
Mar 31, 2023 640.33 Mn
Dec 31, 2022 666.63 Mn
Sep 30, 2022 723.99 Mn
Jun 30, 2022 781.91 Mn
Mar 31, 2022 850.29 Mn
Dec 31, 2021 904.22 Mn
Sep 30, 2021 958.21 Mn
API Access

Kodiak Sciences Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KOD&period=max&api_key=YOUR_API_KEY